ES2061422T3 - Metodos para detectar la resorcion osea in vivo. - Google Patents

Metodos para detectar la resorcion osea in vivo.

Info

Publication number
ES2061422T3
ES2061422T3 ES91900109T ES91900109T ES2061422T3 ES 2061422 T3 ES2061422 T3 ES 2061422T3 ES 91900109 T ES91900109 T ES 91900109T ES 91900109 T ES91900109 T ES 91900109T ES 2061422 T3 ES2061422 T3 ES 2061422T3
Authority
ES
Spain
Prior art keywords
bone resorption
vivo
methods
detect bone
pyridinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91900109T
Other languages
English (en)
Other versions
ES2061422T1 (es
Inventor
David R Eyre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington Research Foundation
Original Assignee
Washington Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27034100&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2061422(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/444,881 external-priority patent/US5140103A/en
Application filed by Washington Research Foundation filed Critical Washington Research Foundation
Publication of ES2061422T1 publication Critical patent/ES2061422T1/es
Application granted granted Critical
Publication of ES2061422T3 publication Critical patent/ES2061422T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/105—Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

METODOS DE DETERMINACION DE LA DEGRADACION DEL COLAGENO IN VIVO, MEDIANTE LA CUANTIFICACION DE UN PEPTIDO EN UN CUERPO LIQUIDO, SIENDO EL PEPTIDO UN TELOPEPTIDO DE COLAGENO DEL TIPO II C-TERMINAL QUE CONTIENE UNA LIGADURA TRANSVERSAL DE PIRIDINOLINA DE HIDROXILISILO O UN TELEPEPTIDO DE COLAGENO DE TIPO III QUE CONTIENE UNA LIGADURA TRANSVERSAL DE PIRIDINOLINA DE HIDROXILISILO. ALGUNOS METODOS ADECUADOS PARA LA CUANTIFICACION INCLUYEN ENSAYOS INMUNOMETRICOS, ENSAYOS FLUOROMETRICOS Y VALORACIONES ELECTROQUIMICAS. SE DESCRIBEN LAS ESTRUCTURAS DE PEPTIDOS ESPECIFICOS CON LIGADURAS TRANSVERSALES Y EFECTOS PARA CUANTIFICAR ESTOS PEPTIDOS EN UN CUERPO LIQUIDO.
ES91900109T 1989-12-01 1990-11-30 Metodos para detectar la resorcion osea in vivo. Expired - Lifetime ES2061422T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/444,881 US5140103A (en) 1987-11-06 1989-12-01 Peptide fragments containing HP and LP cross-links
US07/614,719 US5300434A (en) 1987-11-06 1990-11-21 Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide

Publications (2)

Publication Number Publication Date
ES2061422T1 ES2061422T1 (es) 1994-12-16
ES2061422T3 true ES2061422T3 (es) 1996-03-16

Family

ID=27034100

Family Applications (2)

Application Number Title Priority Date Filing Date
ES91900109T Expired - Lifetime ES2061422T3 (es) 1989-12-01 1990-11-30 Metodos para detectar la resorcion osea in vivo.
ES95201176T Expired - Lifetime ES2133656T3 (es) 1989-12-01 1990-11-30 Metodos para detectar in vivo la degradacion de colageno.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES95201176T Expired - Lifetime ES2133656T3 (es) 1989-12-01 1990-11-30 Metodos para detectar in vivo la degradacion de colageno.

Country Status (13)

Country Link
US (5) US5300434A (es)
EP (6) EP1560026A1 (es)
JP (6) JP2782017B2 (es)
AT (3) ATE133790T1 (es)
AU (1) AU645049B2 (es)
DE (4) DE69033082T2 (es)
DK (3) DK0682256T3 (es)
ES (2) ES2061422T3 (es)
GR (3) GR940300047T1 (es)
IE (1) IE65280B1 (es)
NO (1) NO309483B1 (es)
RU (1) RU2139541C1 (es)
WO (1) WO1991008478A2 (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2551939B1 (fr) * 1983-09-14 1985-10-11 Cit Alcatel Dispositif de transfert et de traitement de voies de donnees ou de signalisation d'un ensemble de lignes multiplex
US6153732A (en) * 1987-11-06 2000-11-28 Washington Research Foundation Kit for detecting analyte indicative of type II collagen resorption in vivo
US6027903A (en) * 1987-11-06 2000-02-22 Washington Research Foundation Kit for detecting analyte indicative of type I collagen resorption in vivo
US5320970A (en) * 1987-11-06 1994-06-14 Washington Research Foundation Detection of collagen degradation in vivo
US5962639A (en) * 1987-11-06 1999-10-05 Washington Research Foundation Synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
GB8929366D0 (en) * 1989-12-30 1990-02-28 Rowett Research Inst Method to detect connective tissue disorder in humans and animals
GB9105893D0 (en) * 1991-03-20 1991-05-08 Orion Yhtymae Oy Bone resorption assay based on a peptide liberated during collagen degradation
US5350855A (en) * 1992-09-30 1994-09-27 Metra Biosystems, Inc. Derivatized D-acyl pyridinium reagent
US6132976A (en) * 1992-12-04 2000-10-17 Shriners Hospitals For Children Immunoassays for the measurement of collagen denaturation and cleavage in cartilage
AU5851494A (en) * 1992-12-17 1994-07-04 Metra Biosystems, Inc. Serum pyridinium crosslinks assay
US5736344A (en) * 1992-12-17 1998-04-07 Metra Biosystems, Inc. Serum pyridinium crosslinks assay
JPH08505149A (ja) * 1992-12-28 1996-06-04 ジェイ． ベイリンク，デビッド 骨再吸収検定法
DK104093D0 (da) * 1993-09-17 1993-09-17 Osteometer A S Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
US6110689A (en) * 1994-01-21 2000-08-29 Osteometer A/S Method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
US5516699A (en) * 1994-02-16 1996-05-14 Institute Of Molecular Biology, Inc. Pyridinoline crosslinks as markers of periodontal and peri-implant disease activity
GB9506050D0 (en) 1995-03-24 1995-05-10 Osteometer A S Assaying collagen fragments in body fluids
JPH10507266A (ja) 1994-10-17 1998-07-14 オステオミーター・ビオ・テク・エー／エス 体液中のコラーゲンの断片化パターンの評価とコラーゲンの代謝に関連する疾患の診断
US5661039A (en) * 1995-03-01 1997-08-26 Metra Biosystems, Inc. Perspiration assay for bone resorption
DE19518232A1 (de) * 1995-05-12 1996-11-14 Ruediger Dr Schade Aviäre, vitelline, gegen Stützgewebe gerichtete Antikörper
US5750647A (en) * 1995-05-19 1998-05-12 Washington Research Foundation Synthetic peptide analogs of NTx
US6107047A (en) * 1996-03-21 2000-08-22 Osteometer Biotech A/S Assaying protein fragments in body fluids
CA2255669A1 (en) * 1996-05-16 1997-11-20 The Texas A & M University System Collagen binding protein compositions and methods of use
GB9617616D0 (en) 1996-08-22 1996-10-02 Osteometer Biotech As Assaying protein fragments in body fluids
ES2160985T3 (es) 1996-12-09 2001-11-16 Osteometer Biotech As Ensayos de tipo sandwich para fragmentos de colageno.
US5834610A (en) * 1997-05-06 1998-11-10 Johnson; Gary M. Conversion of pyridinoline to deoxypyridinoline
US5989925A (en) * 1997-06-27 1999-11-23 Serex, Inc. Antibody to and assay for peptide linked-pyridinoline as indicator of bone resorption level
US5972623A (en) * 1997-07-31 1999-10-26 Metra Biosystems, Inc. Collagen-peptide assay method
US6117646A (en) * 1997-09-22 2000-09-12 Osteometer Biotech A/S Assaying protein fragments in body fluids
US6030792A (en) * 1997-11-13 2000-02-29 Pfizer Inc Assays for measurement of protein fragments in biological media
US6916903B2 (en) * 1998-06-19 2005-07-12 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
US6602980B1 (en) 1998-06-19 2003-08-05 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
US6348320B1 (en) 1998-06-19 2002-02-19 Washington Research Foundation Cartilage resorption assays measuring type II collagen fragments
ATE302949T1 (de) * 1998-06-19 2005-09-15 Washington Res Found Knorpelresorptionsassays
AU776137B2 (en) * 1999-01-06 2004-08-26 University Of Southern California Method and composition for angiogenesis inhibition
ATE278965T1 (de) * 1999-06-17 2004-10-15 Washington Res Found Knorpelresorptionsassays
WO2002029409A2 (en) * 2000-10-03 2002-04-11 Rowett Research Institute Method of assaying pyrrole-containing biological compounds
US20020169288A1 (en) * 2001-03-15 2002-11-14 Magnus Hook Collagen-binding adhesin from staphylococcus epidermidis and method of use
RU2204135C2 (ru) * 2001-07-19 2003-05-10 Научно-исследовательский институт эпидемиологии и микробиологии им. почетного академика Н.Ф. Гамалеи РАМН Способ прижизненного определения цитопролиферативного фактора в организме стареющих млекопитающих и человека
RU2214596C1 (ru) * 2002-05-21 2003-10-20 Подковкин Владимир Георгиевич Способ оценки метаболизма коллагена
CA2574086A1 (en) * 2004-07-21 2006-02-23 Medtronic, Inc. Medical devices and methods for reducing localized fibrosis
US20060030538A1 (en) * 2004-07-21 2006-02-09 Medtronic, Inc. Methods for reducing or preventing localized fibrosis using SiRNA
PT1948235E (pt) 2005-11-01 2013-11-26 Abbvie Biotechnology Ltd Métodos de determinação da eficácia de adalimumab em sujeitos com espondilite anquilosante, utilizando ctx-ii e mmp3 como biomarcadores
JP2007162988A (ja) * 2005-12-12 2007-06-28 Sanden Corp 蒸気圧縮式冷凍サイクル
JP5237366B2 (ja) * 2007-06-20 2013-07-17 メルク・シャープ・アンド・ドーム・コーポレーション 炎症性関節疾患に対する抗ｉｌ−１７ａ治療のための関節破壊のバイオマーカー
EP2538222B1 (en) * 2007-11-05 2021-08-25 Nordic Bioscience A/S Biochemical markers for CVD risk assessment
RU2384842C2 (ru) * 2008-05-26 2010-03-20 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Федерального агентства по здравоохранению и социальному развитию (ГОУВПО ММА им. И.М. Сеченова Росздрава) СПОСОБ КОЛИЧЕСТВЕННОГО ОПРЕДЕЛЕНИЯ ПЕПТИДОВ И ДЕНАТУРИРОВАННЫХ БЕЛКОВ, НЕКОВАЛЕНТНО СВЯЗАННЫХ С БЕЛКОМ ТЕПЛОВОГО ШОКА 70 кДа
US9012160B2 (en) * 2008-06-16 2015-04-21 Abraham Amir Monitoring skin metabolism products for evaluating burn injury
CN102482348B (zh) * 2009-09-16 2014-08-27 盐野义制药株式会社 胶原新表位抗体
ES2679918T3 (es) 2010-02-18 2018-08-31 Vtv Therapeutics Llc Derivados de imidazol condensados sustituidos, composiciones farmacéuticas y métodos de uso de los mismos
US8759535B2 (en) 2010-02-18 2014-06-24 High Point Pharmaceuticals, Llc Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
USRE49477E1 (en) 2012-04-20 2023-03-28 Thomas Jefferson University Engineered antibody for inhibition of fibrosis
WO2017098321A1 (en) 2015-12-11 2017-06-15 Spartan Bioscience Inc. Tube sealing system and methods for nucleic acid amplification
WO2023068249A1 (ja) * 2021-10-20 2023-04-27 積水メディカル株式会社 Ｉ型コラーゲン架橋ｎ－テロペプチドの測定試薬、その調製方法、及びそれを用いた免疫測定方法
US20250172570A1 (en) * 2021-10-20 2025-05-29 Sekisui Medical Co., Ltd. Immunoassay method for cross-linked n-telopeptide of type i collagen, immunoassay kit, and antibody or antibody fragment thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6716836A (es) * 1967-12-11 1969-06-13
JPS5164788A (ja) * 1974-12-03 1976-06-04 Orion Yakuhin Kogyo Kk Shodokuyomennometsukinhoho
US4094646A (en) * 1977-06-02 1978-06-13 The Baltimore Spice Company Rapid method of assaying collagen in meat and meat products
LU78457A1 (fr) * 1977-11-04 1979-06-13 Prayon Soc Procede de fabrication d'acide phosphorique
DE2816841A1 (de) * 1978-04-18 1979-10-31 Max Planck Gesellschaft Radioimmunologische bestimmung von prokollagen (typ iii) und prokollagen- peptid (typ iii)
US4298593A (en) * 1979-08-21 1981-11-03 Abbott Laboratories Reagents and methods utilizing labeled Fab bound to antigens
US4371374A (en) * 1980-11-17 1983-02-01 The Rockefeller University Monitoring metabolic control in diabetic patients by measuring glycosylated amino acids and peptides in urine
DE3209149A1 (de) * 1982-03-13 1983-10-06 Hoechst Ag Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum
CA1229789A (en) * 1983-06-06 1987-12-01 David Baylink Polypeptides exhibiting skeletal growth factor activity
JPS60198156A (ja) * 1984-03-19 1985-10-07 凸版印刷株式会社 プラスチツク製品の殺菌方法
JPS60256457A (ja) * 1984-06-01 1985-12-18 大日本印刷株式会社 包装材料の殺菌方法
US4731326A (en) * 1984-06-04 1988-03-15 Ortho Diagnostic Systems Inc. Disease diagnosis by detection of shed normal tissue antigens
US4774227A (en) * 1986-02-14 1988-09-27 Collagen Corporation Collagen compositions for bone repair containing autogeneic marrow
DE3851776T2 (de) * 1987-04-28 1995-05-04 Boehringer Mannheim Gmbh Verwendung von IGF-II zur Behandlung von Knochenkrankheiten.
GB2205643B (en) * 1987-05-08 1991-03-13 Farmos Group Limited Type iii collagen degradation assay
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
US5320970A (en) * 1987-11-06 1994-06-14 Washington Research Foundation Detection of collagen degradation in vivo
GB8815174D0 (en) * 1988-06-25 1988-08-03 Rowett Research Inst Method of monitoring collagen degradation
AU645742B2 (en) * 1988-10-24 1994-01-27 Bruce Caterson Methods of and compositions for diagnosing, monitoring and treating the early stages of osteoarthritis
WO1990008195A1 (en) * 1989-01-13 1990-07-26 President And Fellows Of Harvard College Monoclonal antibody to human type ix collagen
GB9105893D0 (en) * 1991-03-20 1991-05-08 Orion Yhtymae Oy Bone resorption assay based on a peptide liberated during collagen degradation

Also Published As

Publication number Publication date
EP0682256B1 (en) 2004-10-13
NO922149L (no) 1992-07-29
EP1560026A1 (en) 2005-08-03
EP0502928B1 (en) 1996-01-31
JP2002139492A (ja) 2002-05-17
EP0682257B1 (en) 1999-04-28
JPH09113510A (ja) 1997-05-02
US5656439A (en) 1997-08-12
JPH10260183A (ja) 1998-09-29
DE502928T1 (de) 1994-08-18
US5300434A (en) 1994-04-05
JP2999416B2 (ja) 2000-01-17
DE69025199T2 (de) 1996-05-30
ATE179521T1 (de) 1999-05-15
NO922149D0 (no) 1992-05-29
RU2139541C1 (ru) 1999-10-10
IE65280B1 (en) 1995-10-18
EP0682257A1 (en) 1995-11-15
ATE133790T1 (de) 1996-02-15
AU645049B2 (en) 1994-01-06
EP0502928A1 (en) 1992-09-16
DE69033082D1 (de) 1999-06-02
JP2000055915A (ja) 2000-02-25
GR940300047T1 (en) 1994-07-29
AU6889891A (en) 1991-06-26
US5473052A (en) 1995-12-05
US5576189A (en) 1996-11-19
US5677198A (en) 1997-10-14
EP0890840A2 (en) 1999-01-13
ATE279730T1 (de) 2004-10-15
DK0682256T3 (da) 2005-02-14
GR3030646T3 (en) 1999-10-29
IE904344A1 (en) 1991-06-05
DE69034170D1 (de) 2004-11-18
ES2061422T1 (es) 1994-12-16
JP2782017B2 (ja) 1998-07-30
NO309483B1 (no) 2001-02-05
JP2000050865A (ja) 2000-02-22
JP3299941B2 (ja) 2002-07-08
DK0502928T3 (da) 1996-02-19
ES2133656T3 (es) 1999-09-16
EP1632502A1 (en) 2006-03-08
WO1991008478A3 (en) 1991-11-28
DE69034170T2 (de) 2006-03-02
DE69033082T2 (de) 1999-09-30
GR3018852T3 (en) 1996-05-31
JPH05502223A (ja) 1993-04-22
JP2999444B2 (ja) 2000-01-17
WO1991008478A2 (en) 1991-06-13
EP0890840A3 (en) 2000-05-17
DE69025199D1 (de) 1996-03-14
EP0682256A1 (en) 1995-11-15
DK0682257T3 (da) 1999-11-08

Similar Documents

Publication Publication Date Title
ES2133656T3 (es) Metodos para detectar in vivo la degradacion de colageno.
ATE111228T1 (de) Verfahren zur überwachung des kollagenabbaus.
NO890071D0 (no) Nedbrytningsanalyse for kollagen type iii.
DE3852827D1 (de) Test von einer körperflüssigkeit zur messung von knochenresorption.
ATE169739T1 (de) Verfahren zum nachweis des abbaus von typ-i- kollagen
PT735369E (pt) Medidor de tempo quimico para uma tira reagente de ensaio de leitura directa
EP0670493A3 (en) Test for the detection of proteins in a biological sample.
ES2118062T3 (es) Composiciones reactivas, metodos y reactivos para la valoracion cuantitativa de magnesio o de calcio y magnesio.
NO953770L (no) Analysemetode
ES2179081T3 (es) Procedimiento para la deteccion de perturbaciones del sistema de proteina c/proteina s.
ATE354088T1 (de) Verfahren zur quantifizierung von oxidiertes glutathion
KR910700456A (ko) 자유 라디칼을 이용한 생체조직 또는 잠재성 응집제의 항-산화성의 분석 또는 방법
BR9612475A (pt) Método de determinação do estado hepático de uma pessoa incluíndo um beneficiário para transplante de figado
ATE223055T1 (de) Verfahren zur diagnose von chlamydia in einer biologischen extrazellulären flüssigkeit
ATE186600T1 (de) Phosphattest
DE69307707D1 (de) TESTSYSTEM FüR DEGENERATIVE MUSKELERKRANKUNGEN

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 502928

Country of ref document: ES